Last updated on August 2018

Pneumonia Vaccine

Brief description of study

Healthy Volunteers Needed for an Investigational Vaccine Study

A clinical research study to evaluate an investigational vaccine against infections caused by Streptococcus pneumoniae is now accepting study volunteers.

Streptococcus pneumoniae is one of the leading causes of bacteremia (S. pneumoniae in the blood), bacterial meningitis, pneumonia, and middle ear infections and continues to be a major global public health concern. Serious pneumococcal disease may occur at any age. Adults of advanced age, with certain existing medical conditions, or weakened immune systems, are at increased risk. 

Eligible participants must be:

  • Generally healthy adults, including those with stable preexisting diseases
  • Men or women, 65 through 85 years of age, who have previously been vaccinated with Prevnar 13 more than 2 months prior to investigational product administration.
  • Available for the entire duration of the study, approximately 12 months.

There will be no costs involved for eligible participants. Reasonable reimbursement will be provided for travel expenses. 

Clinical Study Identifier: TX155626

Contact Investigators or Research Sites near you

Start Over
Sorry. There are no research Sites conducting this study in the radius provided. ( View all Sites )

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.